Skip to main content

Table 3 Comparison of demographic and baseline outcome data by recommended final treatment for all participants and for those treated at HIAE and adjusted mean differences in change scores for those treated at HIAE

From: Second opinion for degenerative spinal conditions: an option or a necessity? A prospective observational study

 

All participants

Participants treated at HIAE

 

Surgery (N = 143)b

CM (N = 235)a

 

Surgery (N = 67)

CM (N = 99)

 

Surgery (N = 67)

CM (N = 99)

 
  

p-valuec

Baseline

p-valuec

12 months

Adjusted mean difference between groups (95% CI)d

   

N

 

N

  

N

 

N

  

Female, N (%)

75 (52)

120 (51)

0.8

67

30 (45)

99

47 (47)

0.7

     
 

Mean (SD)

Mean (SD)

  

Mean (SD)

 

Mean (SD)

  

Mean (SD)

 

Mean (SD)

 

Age, years

45.2 (12.6)

42.3 (10.7)

0.02

67

44.3 (10.6)

99

46.8 (14.5)

0.2

     

Pain (0 to 10)e

7.8 (2.2)

7.3 (2.1)

0.03

67

7.6 (2.4)

99

7.0 (2.2)

0.1

57

3.1 (3.0)

77

3.4 (3.3)

0.53 (−0.53 to 1.60)

SF 36 (0–100)f

 VT

38.5 (23.5)

38.5 (21.2)

0.99

67

41.6 (26.5)

98

39.4 (21.5)

0.6

54

63.3 (23.4)

79

61.5 (24.3)

−1.6 (−9.1 to 5.9)

 PF

32.9 (17.5)

35.3 (18.4)

0.2

66

38.6 (19.5)

98

38.9 (19.5)

0.9

54

64.4 (23.7)

79

62.2 (25.6)

−3.3 (−11.4 to 4.7)

 BP

22.8 (18.1)

28.2 (18.3)

0.006

67

25.7 (20.8)

98

30.2 (19.9)

0.2

54

63.4 (27.5)

79

58.2 (30.5)

−7.3 (−17.4 to 2.9)

 GH

55.5 (23.5)

55.1 (22.1)

0.9

66

59.2 (23.43)

99

57.2 (21.5)

0.6

54

76.6 (23.1)

79

69.6 (24.0)

−6.6 (−14.3 to 1.1)

 RP

18.3 (26.4)

28.4 (32.6)

0.002

67

10.8 (26.5)

98

22.2 (37.1)

0.03

54

59.3 (46.4)

79

56.3 (46.9)

−8.1 (−24.4 to 8.2)

 RE

28.4 (40.0)

36.7 (43.4)

0.1

67

27.4 (40.2)

98

34.1 (43.8)

0.2

54

80.9 (38.6)

79

73.8 (42.9)

−9.4 (−23.7 to 5.0)

 SF

22.8 (28.6)

27.5 (31.8)

0.2

67

38.4 (27.9)

98

45.7 (27.5)

0.1

54

73.6 (29.3)

79

70.3 (32.6)

−5.0 (−15.7 to 5.8)

 MH

48.8 (22.9)

49.5 (22.4)

0.8

67

50.7 (24.5)

98

48.4 (23.4)

0.5

54

73.8 (23.4)

79

69.2 (27.1)

−4.1 (−12.4 to 4.2)

 HT

30.9 (25.9)

31.1 (23.5)

0.9

67

27.6 (25.4)

98

34.2 (24.2)

0.1

54

75.5 (26.8)

79

70.6 (27.4)

−4.9 (−14.5 to 4.7)

RMDQ (0–24)e

17.3 (4.8)

13.5 (5.8)

<0.001

56

18.1 (4.4)

75

12.3 (5.4)

<0.001

48

8.8 (7.5)

61

8.3 (6.8)

1.5 (−1.6 to 4.7)

ODI (0–100)e

50.1 (16.9)

42.2 (16.3)

<0.001

56

47.8 (17.4)

75

42.8 (16.0)

0.1

48

28.1 (18.9)

60

27.4 (19.3)

0.1 (−7.1 to 7.3)

  1. aNs for outcome variables range from 170 to 221; bNs for outcome variables range from 112 to 135; c p-values from linear regression; dAdjusted for baseline score of outcome variable; eHigher scores indicate greater pain or disability; fHigher scores indicate better quality of life or function
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us